quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:09:48·1366d
NEWSRelease
Cortexyme Inc. logo

Cortexyme Corporate Name Change To Quince Therapeutics To Take Effect On August 1, 2022

CRTX· Cortexyme Inc.
Health Care
Original source

Companies

  • CRTX
    Cortexyme Inc.
    Health Care

Recent analyst ratings

  • Mar 9UpdateHC Wainwright & Co.$15.00
  • Jan 28UpdateCanaccord Genuity$12.00
  • Jan 28UpdateCanaccord Genuity-
  • Jan 27UpdateJMP Securities-
  • Oct 27UpdateB of A Securities-
  • Oct 27UpdateBofA Securities$15.00

Related

  • SEC1224d
    Cortexyme Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • INSIDER1233d
    SEC Form 4: Monohon Ted covered exercise/tax liability with 1,640 shares, decreasing direct ownership by 5% to 29,311 units to cover taxes
  • SEC1261d
    SEC Form 10-Q filed by Cortexyme Inc.
  • SEC1301d
    Cortexyme Inc. filed SEC Form 8-K: Leadership Update
  • INSIDER1323d
    SEC Form 4: Monohon Ted covered exercise/tax liability with 1,520 shares, decreasing direct ownership by 5% to 30,951 units to cover taxes
  • SEC1361d
    Cortexyme Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
  • NEWS1365d
    Stocks That Hit 52-Week Lows On Thursday
  • NEWS1366d
    Recap of Wednesday's Biotech Catalysts - End of The Day Summary
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022